Your browser doesn't support javascript.
loading
Glucocorticoid- and Transplantation-Induced Osteoporosis.
Zavatta, Guido; Clarke, Bart L.
Afiliação
  • Zavatta G; Mayo Clinic E18-A, 200 1st Street Southwest, Rochester, MN 55905, USA; Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum, University of Bologna, Policlinico di S. Orsola - Padiglione 11, Via Massarenti 9, Bologna 40138, Italy.
  • Clarke BL; Mayo Clinic E18-A, 200 1st Street Southwest, Rochester, MN 55905, USA. Electronic address: clarke.bart@mayo.edu.
Endocrinol Metab Clin North Am ; 50(2): 251-273, 2021 06.
Article em En | MEDLINE | ID: mdl-34023042
Glucocorticoid-induced osteoporosis is the most common cause of secondary osteoporosis; nonetheless, it remains an undertreated condition. Transplantation-induced osteoporosis encompasses a broad range of unique pathogenetic features with distinct characteristics dependent on the transplanted organ. Understanding the pathogenesis of bone loss is key to recommending osteoporosis therapy in these patients. This review summarizes recent advances and addresses current issues in these fields.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Glucocorticoides Limite: Humans Idioma: En Revista: Endocrinol Metab Clin North Am Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Glucocorticoides Limite: Humans Idioma: En Revista: Endocrinol Metab Clin North Am Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália